Article
Publicly Available
Masthead
Published/Copyright:
December 14, 2013
Published Online: 2013-12-14
Published in Print: 2014-01-01
©2014 by Walter de Gruyter Berlin Boston
Articles in the same Issue
- Masthead
- Masthead
- Editorial
- Frontiers in research on the Maillard reaction in aging and chronic disease
- Reviews
- Role of the Maillard reaction in aging and age-related diseases. Studies at the cellular-molecular level
- Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review
- Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications
- Mini Reviews
- Post-translational modification derived products (PTMDPs): toxins in chronic diseases?
- Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes
- Augmentation of blood lipid glycation and lipid oxidation in diabetic patients
- Maillard reaction products: some considerations on their health effects
- The Maillard reaction and food allergies: is there a link?
- Perspectives
- Chelation therapy for the management of diabetic complications: a hypothesis and a proposal for clinical laboratory assessment of metal ion homeostasis in plasma
- Genetics and Molecular Diagnostics
- Genetic variability in enzymes of metabolic pathways conferring protection against non-enzymatic glycation versus diabetes-related morbidity and mortality
- General Clinical Chemistry and Laboratory Medicine
- Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen
- A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes
- Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients
- Circulating soluble RAGE increase after a cerebrovascular event
- Pentosidine determination in CSF: a potential biomarker of Alzheimer’s disease?
- Cardiovascular Diseases
- Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years
- Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure
- Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects
- Translational Research Papers
- Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells
- Formation of nitri- and nitrosylhemoglobin in systems modeling the Maillard reaction
- Skin aging by glycation: lessons from the reconstructed skin model
- How to help the skin cope with glycoxidation
Articles in the same Issue
- Masthead
- Masthead
- Editorial
- Frontiers in research on the Maillard reaction in aging and chronic disease
- Reviews
- Role of the Maillard reaction in aging and age-related diseases. Studies at the cellular-molecular level
- Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review
- Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications
- Mini Reviews
- Post-translational modification derived products (PTMDPs): toxins in chronic diseases?
- Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes
- Augmentation of blood lipid glycation and lipid oxidation in diabetic patients
- Maillard reaction products: some considerations on their health effects
- The Maillard reaction and food allergies: is there a link?
- Perspectives
- Chelation therapy for the management of diabetic complications: a hypothesis and a proposal for clinical laboratory assessment of metal ion homeostasis in plasma
- Genetics and Molecular Diagnostics
- Genetic variability in enzymes of metabolic pathways conferring protection against non-enzymatic glycation versus diabetes-related morbidity and mortality
- General Clinical Chemistry and Laboratory Medicine
- Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen
- A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes
- Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients
- Circulating soluble RAGE increase after a cerebrovascular event
- Pentosidine determination in CSF: a potential biomarker of Alzheimer’s disease?
- Cardiovascular Diseases
- Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years
- Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure
- Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects
- Translational Research Papers
- Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells
- Formation of nitri- and nitrosylhemoglobin in systems modeling the Maillard reaction
- Skin aging by glycation: lessons from the reconstructed skin model
- How to help the skin cope with glycoxidation